Margaret Chan: committed to universal health coverage.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 22959376)

Published in Lancet on September 08, 2012

Authors

David Holmes

Articles by these authors

(truncated to the top 100)

Sinus of Valsalva aneurysms--47 years of a single center experience and systematic overview of published reports. Am J Cardiol (2007) 5.71

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA (2007) 2.99

West African Ebola epidemic after one year--slowing but not yet under control. N Engl J Med (2014) 2.96

Outcomes following transcatheter aortic valve replacement in the United States. JAMA (2013) 2.88

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation (2013) 2.86

The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol (2012) 2.80

Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation (2011) 2.66

Endocrine disruptors cause toxic fallout. Lancet Diabetes Endocrinol (2013) 2.56

Assessment of the SYNTAX score in the Syntax study. EuroIntervention (2009) 2.24

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes. J Clin Endocrinol Metab (2004) 2.21

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. Diabetes Care (2002) 1.73

Global regulation of gene expression by ArlRS, a two-component signal transduction regulatory system of Staphylococcus aureus. J Bacteriol (2005) 1.72

Inactivation of a two-component signal transduction system, SaeRS, eliminates adherence and attenuates virulence of Staphylococcus aureus. Infect Immun (2006) 1.63

Initial clinical results using intracardiac electrogram monitoring to detect and alert patients during coronary plaque rupture and ischemia. J Am Coll Cardiol (2010) 1.54

Chronic disease care crisis for Lebanon's Syrian refugees. Lancet Diabetes Endocrinol (2014) 1.50

Metabolic reconstruction of sulfur assimilation in the extremophile Acidithiobacillus ferrooxidans based on genome analysis. BMC Genomics (2003) 1.44

What patients think: patient-reported outcomes of retropubic versus trans-obturator mid-urethral slings for urodynamic stress incontinence--a multi-centre randomised controlled trial. Int Urogynecol J (2011) 1.41

UK moves to ensure "access to unlicensed herbal medicines". Lancet (2011) 1.40

NICE epilepsy guidance "may be detrimental to patient care". Lancet (2012) 1.40

Air quality gives UK Government a headache. Lancet Respir Med (2014) 1.39

Hyper-adhesion in desmosomes: its regulation in wound healing and possible relationship to cadherin crystal structure. J Cell Sci (2005) 1.32

Buy buy bispecific antibodies. Nat Rev Drug Discov (2011) 1.14

Preparation and analysis of an expressed sequence tag library from the toxic dinoflagellate Alexandrium catenella. Mar Biotechnol (NY) (2008) 1.13

Technology insight: in vivo coronary plaque classification by intravascular ultrasonography radiofrequency analysis. Nat Clin Pract Cardiovasc Med (2008) 1.09

High speed multi-frequency impedance analysis of single particles in a microfluidic cytometer using maximum length sequences. Lab Chip (2007) 1.09

Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation (2003) 1.08

Prescription drug addiction: the treatment challenge. Lancet (2012) 1.04

The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion. J Clin Endocrinol Metab (2007) 1.03

FDA paves the way for pre-exposure HIV prophylaxis. Lancet (2012) 1.02

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation. J Am Coll Cardiol (2013) 0.97

After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics. N Engl J Med (2016) 0.94

Rwanda: an injection of hope. Lancet (2010) 0.94

Diffractive micro bar codes for encoding of biomolecules in multiplexed assays. Anal Chem (2008) 0.94

PI3K pathway inhibitors approach junction. Nat Rev Drug Discov (2011) 0.92

Anti-NGF painkillers back on track? Nat Rev Drug Discov (2012) 0.90

MERS-CoV enigma deepens as reported cases surge. Lancet (2014) 0.89

IARC in the dock over ties with asbestos industry. Lancet (2013) 0.88

Phylogenomic and biochemical characterization of three Legionella pneumophila polypeptide deformylases. J Bacteriol (2006) 0.87

Report triggers quibbles over QALYs, a staple of health metrics. Nat Med (2013) 0.86

Rationale and study design of the CardioGene Study: genomics of in-stent restenosis. Pharmacogenomics (2004) 0.85

Cancer drug's survivin suppression called into question. Nat Med (2012) 0.85

Micro-impedance cytometry for detection and analysis of micron-sized particles and bacteria. Lab Chip (2010) 0.85

Noise reduction to decrease radiation dose and improve conspicuity of hepatic lesions at contrast-enhanced 80-kV hepatic CT using projection space denoising. AJR Am J Roentgenol (2012) 0.85

Mapping high-fidelity volume rendering for medical imaging to CPU, GPU and many-core architectures. IEEE Trans Vis Comput Graph (2009) 0.84

End-stage renal disease: Link between prehypertension and risk of ESRD grows stronger. Nat Rev Nephrol (2013) 0.84

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J (2005) 0.84

ebrain brings the e-learning revolution to the neurosciences. Lancet Neurol (2012) 0.83

ICE Afe 1, an actively excising genetic element from the biomining bacterium Acidithiobacillus ferrooxidans. J Mol Microbiol Biotechnol (2013) 0.83

Current computed tomography techniques can detect duct of Bellini plugging but not Randall's plaques. Urology (2013) 0.83

Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. Circ Cardiovasc Qual Outcomes (2011) 0.82

Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressor. Oncogene (2004) 0.82

Europe plays catch-up on neonatal screening as US skips ahead. Nat Med (2012) 0.81

Investigation of the first laboratory-acquired human cowpox virus infection in the United States. J Infect Dis (2012) 0.81

The cancer that rises with the sun. Nature (2014) 0.81

Primary care education: measuring instruction to improve quality. Acad Med (2002) 0.81

Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. J Am Coll Cardiol (2011) 0.81

Ovarian cancer: beyond resistance. Nature (2015) 0.81

Mind the IGAP. Lancet Neurol (2011) 0.80

A disease of growth. Nature (2015) 0.80

Maximising the potential of part-time clinical teachers. Clin Teach (2010) 0.80

Biomarkers: Sclerostin levels linked to CKD outcomes. Nat Rev Endocrinol (2014) 0.79

Efficacy and safety of nateglinide in type 2 diabetic patients with modest fasting hyperglycemia. J Clin Endocrinol Metab (2002) 0.79

Stereoscopic Depth Perception during Binocular Rivalry. Front Hum Neurosci (2011) 0.79

The problem with platinum. Nature (2015) 0.79

New initiative aims to tackle shortfalls in mental health crisis care. Lancet Psychiatry (2014) 0.79

Loa loa: neglected neurology and nematodes. Lancet Neurol (2013) 0.78

Bruno Dubois: transforming the diagnosis of Alzheimer's disease. Lancet Neurol (2014) 0.78

Generation and analysis of expressed sequence tags from Botrytis cinerea. Biol Res (2006) 0.78

Dual-cycle dielectrophoretic collection rates for probing the dielectric properties of nanoparticles. Electrophoresis (2013) 0.78

A new chapter in innovation. Nature (2016) 0.78

Rationale and design of the randomized, multicenter, cilostazol for RESTenosis (CREST) trial. Clin Cardiol (2003) 0.77

Report urges controversial 'delinkage' to foster new antibiotics. Nat Med (2014) 0.77

Integrin inhibitors go with the gut. Nat Rev Drug Discov (2013) 0.77

Parathyroid function: Key role for dicer-dependent miRNAs. Nat Rev Endocrinol (2015) 0.77

Skies darken over drug companies. Lancet (2012) 0.77

A technique for quantifying wrist motion using four-dimensional computed tomography: approach and validation. J Biomech Eng (2015) 0.77

Gail Davey: raising the profile of "podo…what?". Lancet (2012) 0.77

The cancer-virus cures. Nat Med (2014) 0.77

Epigenetics: Don't stress dad - it's bad for your kids' health. Nat Rev Endocrinol (2016) 0.77

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry. EuroIntervention (2011) 0.77

vCJD remains an enigma as UK deaths fall to zero for 2012. Lancet Infect Dis (2012) 0.77

Psychophysiologic responses of invasive cardiologists in an academic catheterization laboratory. Am Heart J (2006) 0.77

The next big things are tiny. Lancet Neurol (2013) 0.77

Addiction: 4 big questions. Nature (2015) 0.77

Evaluation of the WATCHMAN left atrial appendage closure device. Expert Rev Med Devices (2014) 0.77

Can technology reveal the natural history of epilepsy? Lancet Neurol (2014) 0.77

The GHIT fund shows its cards. Nat Rev Drug Discov (2013) 0.76

Smoking in Russia: will old habits die hard? Lancet (2011) 0.76

Music therapy's breakthrough act. Lancet Neurol (2012) 0.76

FDA treads carefully with PrEP. Lancet Infect Dis (2012) 0.76

Lixin Jiang: at the heart of China's evidence base. Lancet (2012) 0.76

Trying to unravel the mysteries of chemobrain. Lancet Neurol (2013) 0.76

Thyroid cancer: Incidence trends in the USA. Nat Rev Endocrinol (2016) 0.76

Impedance spectroscopy and optical analysis of single biological cells and organisms in microsystems. Methods Mol Biol (2010) 0.76

Is neurology ready to see the light? Lancet Neurol (2012) 0.76

Epigenetics: On-off switch for obesity. Nat Rev Endocrinol (2016) 0.76

XMRV controversy laid to rest. Lancet Infect Dis (2012) 0.76

Metabolism: kisspeptin signalling linked to obesity. Nat Rev Endocrinol (2014) 0.76

Recurrent dyspnea following multiple ablations for atrial fibrillation explained by the "stiff left atrial syndrome". Catheter Cardiovasc Interv (2013) 0.75

Frequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-up. Am J Cardiol (2006) 0.75